viernes, 15 de enero de 2016

CDRH Industry: Workshop - Next Generation Sequencing-Based Oncology Panels

The Food and Drug Administration (FDA) is announcing the public workshop “Next Generation Sequencing-Based Oncology Panels.”
Date: February 25, 2016
Purpose: To obtain feedback on analytical and clinical validation approaches for next generation sequencing (NGS)-based oncology panels. Comments and suggestions generated through this workshop will help guide the development of appropriate regulatory standards for evaluation of NGS-based oncology panels in cancer patient management.

No hay comentarios: